🔎 Trials Near Me

Home › Kanser sa Ulo at Leeg › North Carolina

Pag-aaral pangklinika para sa Kanser sa Ulo at Leeg sa North Carolina

14 pag-aaral para sa Kanser sa Ulo at Leeg ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Duke University, Durham
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Site#0118, Durham
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06788990

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Novant Health Cancer Institute - Kernersville, Kernersville
  • Novant Health Cancer Institute - Mount Airy, Mount Airy
  • Novant Health Forsyth Medical Center, Winston-Salem
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

DESTINY-PANTUMOUR04

  • Research Site, Durham
  • Research Site, Wilson
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

  • Levine Cancer Institute, Charlotte
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06607406

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06096038

Effects of Infusion Timing on Treatment Response in Solid Tumors

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07630168

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Carolina BioOncology Institute, Huntersville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06993844

Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma

  • University of North Carolina at Chapel Hill, Chapel Hill
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 6, 2026 · NCT04099290

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 3, 2026 · NCT07278557

X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

  • Levine Cancer Institute, Charlotte
  • Duke University, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 30, 2026 · NCT04389281

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

  • Duke University Medical Center, Durham
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT05793151

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chapel Hill
  • Massive Bio SYNERGY-AI site, Winston-Salem
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Levine Cancer Institute, Charlotte
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 15, 2025 · NCT04429542

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.